By Megan Brooks
Medscape Medical News
Aug. 5, 2014 -- There's been little change in the top-prescribed and top-selling prescription drugs in the United States, according to the latest data from research firm IMS Health.
Synthroid (levothyroxine) continues to be the nation's most-prescribed drug, and the antipsychotic Abilify (aripiprazole) continues to have the highest sales.
The data reflect a rolling 12 months of history (July 2013 - June 2014) on the top 100 drugs by total sales and total prescriptions in the U.S.
The top 10 drugs by number of monthly prescriptions are:
- Synthroid, 22.6 million
- Crestor, 22.5 million
- Nexium, 18.6 million
- Ventolin HFA, 17.5 million
- Advair Diskus, 15.0 million
- Diovan, 11.4 million
- Lantus Solostar, 10.1 million
- Cymbalta, 10.0 million
- Vyvanse, 10.0 million
- Lyrica, 9.6 million
The top 10 drugs by sales are:
- Abilify, $7.2 billion
- Humira, $6.3 billion
- Nexium, $6.3 billion
- Crestor, $5.6 billion
- Enbrel, $5.0 billion
- Advair Diskus, $5.0 billion
- Sovaldi, $4.4 billion
- Remicade, $4.3 billion
- Lantus Solostar, $3.8 billion
- Neulasta, $3.6 billion
The complete list of the top 100 can be found on Medscape.
source : Top 10 Most Prescribed, Top-Selling Drugs
